SCHEMBL4190873

SCHEMBL4190873

c1cc2c(ccc3ncsc32)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.41
HTT P42858 2/20 0.41
ALDH1A1 P00352 1/20 0.41
NCOA1 Q15788 1/20 0.41
NCOA3 Q9Y6Q9 1/20 0.41
IMPDH2 P12268 4/20 0.40
LMNA P02545 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
MAPKAPK2 P49137 1/20 0.38
ERN1 O75460 1/20 0.37
CDK4 P11802 1/20 0.35
CCND1 P24385 1/20 0.35
CACNA1B Q00975 1/20 0.35
CCR4 P51679 1/20 0.34
MAPK10 P53779 6/20 0.33
MAPK8 P45983 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11372655 0.86 MAPK10 (0.43) KDM4EHTTALDH1A1NCOA1NCOA3
SCHEMBL29871387 0.76 CYP3A4 (0.47) KDM4EALDH1A1LMNACYP3A4
SCHEMBL2852558 0.76 CYP3A4 (0.47) KDM4EALDH1A1LMNACYP3A4
SCHEMBL9980542 0.71 EGFR (0.37) ALDH1A1
SCHEMBL2722669 0.71 ALDH1A1 (0.46) KDM4EALDH1A1
SCHEMBL445595 0.71 IMPDH2 (0.58) KDM4EHTTALDH1A1NCOA1NCOA3
SCHEMBL30929170 0.70 EGFR (0.35) ALDH1A1
SCHEMBL3745133 0.70 EGFR (0.35) ALDH1A1
SCHEMBL28874626 0.70 CYP1A2 (0.43) KDM4EALDH1A1LMNACYP1A2
SCHEMBL29966792 0.70 CYP1A2 (0.43) KDM4EALDH1A1LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1478363-B1 FUSED AZABICYCLIC COMPOUNDS THAT INHIBIT VANILLOID RECEPTOR SUBTYPE 1 (VR1) RECEPTOR ABBOTT LAB (US) 2009-01-14 EP disclosed
EP-1660455-B1 FUSED AZABICYCLIC COMPOUNDS THAT INHIBIT VANILLOID RECEPTOR SUBTYPE 1 (VR1) RECEPTOR ABBOTT LAB (US) 2008-10-15 EP disclosed